Boston, Massachusetts, United States
Accomplished, results-oriented Computational Scientist with significant expertise in identification of computational needs and subsequent planning and implementation of workflows and pipelines. Experienced, team-oriented manager and mentor. 15 years of experience in analyzing large-scale genomic and proteomic data with a special focus on integrative analysis of data derived from multiple omics platforms. Former integral member of the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC).
Established bioinformatic support to advance clinical and pre-clinical programs and strengthen Frontier's platform capabilities.
Leading the development and coordination of bioinformatic strategies across platforms and programs. Building, managing, and mentoring a high-performing team of computational scientists.
Integral member of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the NCI. Coordination of analysis efforts across multiple research institutions within the CPTAC network.
Development and application of computational approaches and pipelines for the analysis of multi-omics data sets, predominantly derived from cancer cohorts analyzed in the NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC).
Development of proteogenomic data analysis pipelines to study phosphosignaling-affecting mutations in clinical cancer cohorts.
Assembly and assessment of individualized protein databases derived from RNA-seq data. Comparative proteogenomics of human cancer cell lines. Bioinformatics support for research and core facility projects; support in maintenance of a heterogeneous IT environment.
Bioinformatics support for research and core facility projects; support in maintenance of a heterogeneous IT environment.
Ph.D. thesis: High accuracy mass spectrometry in refinement of genome annotation.